Safety/Phase I study of PiggyBac transposon mediated Chimeric Antigen Receptor T cells targeting CD-19 in Thai patients with refractory systemic lupus Erythematosus
August 17, 2025
admin@narisara
0
Research Topics
Safety/Phase I study of PiggyBac transposon mediated Chimeric Antigen Receptor T cells targeting CD-19 in Thai patients with refractory systemic lupus Erythematosus